Healthcare & Life Sciences
GlycoMimetics
United Stateswww.glycomimetics.com
GlycoMimetics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About GlycoMimetics
GlycoMimetics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
GlycoMimetics is a biotechnology company developing glycomimetic therapeutics that inhibit selectin-mediated cell adhesion to treat hematologic disorders and cancer, with clinical-stage candidates for acute myeloid leukemia and sickle cell disease.
Explore GlycoMimetics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.